French beauty company L'Oréal Groupe (Euronext Paris:OR) on Tuesday announced a four-year partnership between its Dermatological Beauty Division and the World Health Organization's WHO Foundation.

Aiming to improve access to skin health treatment in low- and middle-income regions, this initiative will strengthen the WHO's efforts to address skin conditions caused by neglected tropical diseases, climate change and other common conditions such as acne, atopic dermatitis, psoriasis and vitiligo.

The partnership will enhance skin disease surveillance and train healthcare workers to recognise early symptoms, especially in vulnerable communities where conditions often go undiagnosed. WHO will also develop training materials, including the WHO Skin NTDs App, to support healthcare providers.

L'Oréal's contribution is part of its EUR20m, five-year 'Act for Dermatology' programme, which aims to improve access to skin health for the 2.1 billion people globally affected by skin diseases. The WHO Foundation will oversee collaboration between WHO and L'Oréal, advocate for increased skin healthcare access and encourage additional partners to support this initiative.